1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy

Bibliographic Details
Main Authors: Hongyan Li, Zemeng Ma, Xiaoyao Hao, Xiaodong F Liu, Wenwen Dai, Yuxiang Liu, Jinyu Liu, Shukai Xia, Mark Z Ma, Mingjiu Chen, Zeyu Peng
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1827763137530560512
author Hongyan Li
Zemeng Ma
Xiaoyao Hao
Xiaodong F Liu
Wenwen Dai
Yuxiang Liu
Jinyu Liu
Shukai Xia
Mark Z Ma
Mingjiu Chen
Zeyu Peng
author_facet Hongyan Li
Zemeng Ma
Xiaoyao Hao
Xiaodong F Liu
Wenwen Dai
Yuxiang Liu
Jinyu Liu
Shukai Xia
Mark Z Ma
Mingjiu Chen
Zeyu Peng
author_sort Hongyan Li
collection DOAJ
first_indexed 2024-03-11T10:47:56Z
format Article
id doaj.art-532a4be423fe4ca6acb4ba21b8feb4ca
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T10:47:56Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-532a4be423fe4ca6acb4ba21b8feb4ca2023-11-13T21:40:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.11761176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacyHongyan Li0Zemeng Ma1Xiaoyao Hao2Xiaodong F Liu3Wenwen Dai4Yuxiang Liu5Jinyu Liu6Shukai Xia7Mark Z Ma8Mingjiu Chen9Zeyu Peng101Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China2Biosion USA, Inc., Newark, DE, USA1Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China1Biosion, Inc., Nanjing, Jiangsu, China
spellingShingle Hongyan Li
Zemeng Ma
Xiaoyao Hao
Xiaodong F Liu
Wenwen Dai
Yuxiang Liu
Jinyu Liu
Shukai Xia
Mark Z Ma
Mingjiu Chen
Zeyu Peng
1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
Journal for ImmunoTherapy of Cancer
title 1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
title_full 1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
title_fullStr 1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
title_full_unstemmed 1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
title_short 1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
title_sort 1176 bsi 510 a novel bispecific molecule combining an anti siglec 15 antibody with cytokine gm csf for enhanced antitumor efficacy
work_keys_str_mv AT hongyanli 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT zemengma 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT xiaoyaohao 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT xiaodongfliu 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT wenwendai 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT yuxiangliu 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT jinyuliu 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT shukaixia 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT markzma 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT mingjiuchen 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy
AT zeyupeng 1176bsi510anovelbispecificmoleculecombininganantisiglec15antibodywithcytokinegmcsfforenhancedantitumorefficacy